1.
X-ray spacecraft to search for black holes
WASHINGTON, May 12 (UPI) -- The U.S. Food and Drug Administration announced approval of a new formulation of the genetically engineered version of Factor VIIa, a coagulation therapy.
The FDA said the new formulation of the plasma protein that's essential for the blood-clotting allows the product to be stored at room temperature -- up to 81 degrees Fahrenheit -- for as long as two years.
NovoSeven RT -- the new formulation of NovoSeven Coagulation Factor VIIa (Recombinant) -- contains sucrose and L-Methionine, which allows storage at room temperature. The FDA said that is helpful for healthcare facilities with limited refrigerated space. The original formula could be stored for three years at temperatures between 36 and 46 degrees.
NovoSeven RT is indicated for treatment of bleeding and the prevention of surgical bleeding in patients with hemophilia A or B, who have antibodies that neutralize the action of clotting Factors VIII or IX.
NovoSeven RT and NovoSeven Coagulation Factor VIIa are manufactured by Novo Nordisk in Denmark.
|
|
|
|
|
|
| Additional Science News Stories | |
BAILIEBOROUGH, Ireland, May 27 (UPI) --
Two spectators were killed Sunday when a rally car at a race in Bailieborough, Ireland, crashed into a crowd on the side of a rural road, officials said.
|
CANNES, France, May 28 (UPI) --
Austrian director Michael Haneke's film "Amour" won the Cannes Film Festival's top prize, the Palme d'Or, officials said.
|
CAPE CANAVERAL, Fla., May 26 (UPI) --
Astronauts aboard the International Space Station have boarded the unmanned Dragon spacecraft and began unloading supplies, NASA TV showed.
|
Wedding parties told to quiet down ... Jersey falcons put up a squawk ... Man charged in drive-through gun incident ... iCloud sends pics of suspected phone thief ... Watercooler stories from UPI.
|
| Stories | Photos | People | Comments |
View Caption
